Chris Ryall
Managing Director
Active in New York
[javascript protected email address]
Download vCard


Chris is a Managing Director at Finsbury focused on strategic, financial and crisis communications. He has spent time in Finsbury's London and New York offices since joining the firm in 2012. Prior to joining Finsbury, Chris worked for Anglo American, first in Corporate Finance and then managing strategic communications for the Group’s divestment program. His recent transaction experience includes the merger of Kronos and Ultimate Software, Takeda's acquisition of Shire, Nightstar Therapeutics' sale to Biogen, Express Scripts' acquisition by Cigna and the merger of Praxair and Linde Group. Chris holds a Bachelor of Business Science degree from the University of Cape Town, South Africa. 2018 PR Week "40 Under 40" Honoree 2019 M&A Advisor "Emerging Leaders" Award
Back to Our People